Study of Different Magnesium Sulphate Treatments for Severe Preeclampsia in Pregnant Women at Ain Shams University Hospital

What this Trial Is About

This research aims to learn about the effects of different magnesium sulphate treatment plans for pregnant women with severe pre-eclampsia, a condition that raises blood pressure and may cause seizures. The study focuses on understanding the various ways magnesium sulphate is used to prevent seizures in these women. It is a retrospective observational study reviewing data from the past five years at Ain Shams University Maternity Hospital. The study involves reviewing hospital records to describe magnesium sulphate regimens given to women diagnosed with severe pre-eclampsia. Researchers will examine details like dosage, administration routes, timing before and after delivery, and any changes in treatment. They will also note any side effects, signs of magnesium toxicity, seizure occurrences despite treatment, and related complications such as ICU admissions or postpartum issues. Participants past medical data will be collected and analyzed, including lab results, vital signs, and delivery details. The study measures outcomes like seizures within 24 hours of delivery, ICU admissions, magnesium toxicity, and postpartum hemorrhage. Confidentiality will be maintained, and the research will provide insights into how different magnesium sulphate regimens affect women with severe pre-eclampsia.

Different Regimens of Magnesium Sulphate in Patients With Severe Preeclampsia